Disease on EC 7.4.2.10 - ABC-type glutathione transporter
Please use the Disease Search for a specific query.
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Breast Neoplasms
ABC transporter (P-gp/ABCB1, MRP1/ABCC1, BCRP/ABCG2) expression in the developing human CNS.
Breast Neoplasms
Celastrol Inhibits the Proliferation and Decreases Drug Resistance of Cisplatin-Resistant Gastric Cancer SGC7901/DDP Cells.
Breast Neoplasms
Modulation of the spacer in N,N-bis(alkanol)amine aryl ester heterodimers led to the discovery of a series of highly potent P-glycoprotein-based multidrug resistance (MDR) modulators.
Breast Neoplasms
MRP1 but not MDR1 is associated with response to neoadjuvant chemotherapy in breast cancer patients.
Breast Neoplasms
Paeonol reverses paclitaxel resistance in human breast cancer cells by regulating the expression of transgelin 2.
Breast Neoplasms
Prediction of Therapy Response and Prognosis in Leukemias by Flow Cytometric MDR Assays.
Breast Neoplasms
Salvianolic acid A reverses paclitaxel resistance in human breast cancer MCF-7 cells via targeting the expression of transgelin 2 and attenuating PI3 K/Akt pathway.
Breast Neoplasms
Selection of resistant acute myeloid leukemia SKM-1 and MOLM-13 cells by vincristine-, mitoxantrone- and lenalidomide-induced upregulation of P-glycoprotein activity and downregulation of CD33 cell surface exposure.
Breast Neoplasms
The Optimization Design Of Lactoferrin Loaded HupA Nanoemulsion For Targeted Drug Transport Via Intranasal Route.
Colonic Neoplasms
Hypoxia-inducible factor-1? induces multidrug resistance protein in colon cancer.
Gallbladder Neoplasms
miR-145 sensitizes gallbladder cancer to cisplatin by regulating multidrug resistance associated protein 1.
Neoplasms
Celastrol Inhibits the Proliferation and Decreases Drug Resistance of Cisplatin-Resistant Gastric Cancer SGC7901/DDP Cells.
Neoplasms
Combined cytogenetic and array-based comparative genomic hybridization analyses of Wilms tumors: amplification and overexpression of the multidrug resistance associated protein 1 gene (MRP1) in a metachronous tumor.
Neoplasms
Effects of clotrimazole on transport mediated by multidrug resistance associated protein 1 (MRP1) in human erythrocytes and tumour cells.
Neoplasms
MRP1 but not MDR1 is associated with response to neoadjuvant chemotherapy in breast cancer patients.
Neoplasms
p53 mutation, but not in vitro predictor genes of therapeutic efficacy of cisplatin, is clinically relevant in comparing partial and complete responder cases of maxillary squamous cell carcinoma.
Retinoblastoma
In vitro and In silico studies on inhibitory effects of curcumin on multi drug resistance associated protein (MRP1) in retinoblastoma cells.
Xeroderma Pigmentosum
p53 mutation, but not in vitro predictor genes of therapeutic efficacy of cisplatin, is clinically relevant in comparing partial and complete responder cases of maxillary squamous cell carcinoma.
html completed